哈尔滨医科大学学报
哈爾濱醫科大學學報
합이빈의과대학학보
JOURNAL OF HARBIN MEDICAL UNIVERSITY
2009年
6期
603-605,608
,共4页
董家蔷%张剑%聂泽强%王京华%李晓云
董傢薔%張劍%聶澤彊%王京華%李曉雲
동가장%장검%섭택강%왕경화%리효운
骨髓纤维化%继发性%临床特点%骨髓活检%网状纤维染色
骨髓纖維化%繼髮性%臨床特點%骨髓活檢%網狀纖維染色
골수섬유화%계발성%림상특점%골수활검%망상섬유염색
myelofibrosis,secondary%clinical features%bone marrow biopsy%Gomori
目的 研究继发性骨髓纤维化(SMF)患者的临床特点和骨髓活检结果 .方法 80例SMF患者采用网状纤维染色(Gomori),并根据阳性结果 判定纤维化程度.结果 80例患者其主要病因为造血系统恶性疾病(87.5%),以慢性骨髓增殖性疾病最多(占32.5%).就诊时网状纤维阳性程度以"++"~"+++"为主.患者就诊时血红蛋白、血小板与原发性骨髓纤维化存在明显差异(P<0.05).结论 对初诊的造血系统恶性疾病患者应行骨髓活检检查,并在判断治疗过程中密切监测骨髓活检,以判断患者在疾病发展过程中是否合并骨髓纤维化,判定患者病情预后情况.
目的 研究繼髮性骨髓纖維化(SMF)患者的臨床特點和骨髓活檢結果 .方法 80例SMF患者採用網狀纖維染色(Gomori),併根據暘性結果 判定纖維化程度.結果 80例患者其主要病因為造血繫統噁性疾病(87.5%),以慢性骨髓增殖性疾病最多(佔32.5%).就診時網狀纖維暘性程度以"++"~"+++"為主.患者就診時血紅蛋白、血小闆與原髮性骨髓纖維化存在明顯差異(P<0.05).結論 對初診的造血繫統噁性疾病患者應行骨髓活檢檢查,併在判斷治療過程中密切鑑測骨髓活檢,以判斷患者在疾病髮展過程中是否閤併骨髓纖維化,判定患者病情預後情況.
목적 연구계발성골수섬유화(SMF)환자적림상특점화골수활검결과 .방법 80례SMF환자채용망상섬유염색(Gomori),병근거양성결과 판정섬유화정도.결과 80례환자기주요병인위조혈계통악성질병(87.5%),이만성골수증식성질병최다(점32.5%).취진시망상섬유양성정도이"++"~"+++"위주.환자취진시혈홍단백、혈소판여원발성골수섬유화존재명현차이(P<0.05).결론 대초진적조혈계통악성질병환자응행골수활검검사,병재판단치료과정중밀절감측골수활검,이판단환자재질병발전과정중시부합병골수섬유화,판정환자병정예후정황.
Objective To study the clinical features and results of bone marrow biopsy of secondary myelofibrosis(SMF).Methods The Gomori method was used to judge if the patients had MF or were not SMF patients.Results The most important etiology of 80 SMF cases were malignant disease of hematological system(87.5%),among them CMPD were most important(32.5%).The level of reticulin fiber were from"++"~"+++".The level of HGB and PLT in SMF patients had obviously compared with those in IFM patients(P<0.05).Conclusion bone marrow biopsy may be used to intinal malignant disease of hematological system patients,and survey the condition of patients,judge if the patients had MF or not early,and the outcome of patients.